• Separating Growth Inhibition from Cell Death in Cancer

  2026-09-07

  Hannah Schwartz’s dissertation shows that relative viability and fractional viability capture different components of an in vitro anticancer response. Its central practical contribution is a framework for analyzing proliferative arrest, cell killing, and their timing as related but non-interchangeable outcomes.

• PKM2 inhibitor (compound 3k): Assay Solutions

  2026-09-07

  This scenario-driven guide shows how PKM2 inhibitor (compound 3k), SKU B8217, can support reproducible cell viability, proliferation, cytotoxicity, and immunometabolism workflows. It connects product specifications with published PKM2 biology, practical dosing controls, interpretation of cellular IC50 values, and evidence-based vendor selection.

• LY294002 Workflow for PI3K/Akt Studies

  2026-09-05

  LY294002 enables reversible interrogation of class I PI3K activity across proliferation, apoptosis, autophagy, and angiogenesis assays. This practical guide connects dose selection and controls with zebrafish vascular models, cancer workflows, and troubleshooting strategies.

• Isoprenaline Hydrochloride: Research Workflows

  2026-09-04

  Isoprenaline Hydrochloride, also called isoproterenol, supports controlled β-adrenergic stimulation across cardiac, airway, endothelial, and heart–brain assays. This guide translates published model logic into practical workflows, parameter choices, and troubleshooting strategies without treating research conditions as clinical recommendations.

• Hijacking ERAD to Degrade Transmembrane Proteins

  2026-09-04

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule targeted protein degradation platform that recruits the ER-associated degradation pathway to remove transmembrane proteins. The study identifies desonide as a SYVN1-binding warhead, demonstrates highly effective PD-L1 degradation and tumor suppression, and extends the concept to mutant huntingtin protein.

• Exendin-4: From GLP-1 Mechanism to Translation

  2026-09-03

  Exendin-4, also known as exenatide, connects GLP-1 receptor biology with practical workflows for beta cell function research, type 2 diabetes research, and translational manufacturing. This article examines its cAMP-centered mechanism, experimental use, yeast-expression advances, and the limits that researchers must address before moving from assay signal to therapeutic strategy.

• Auranofin Workflows for Redox and Autophagy Research

  2026-09-03

  Use Auranofin as a mechanistically anchored thioredoxin reductase inhibitor in redox, apoptosis, radiosensitization, antimicrobial, and mechanotransduction studies. This guide converts target potency and cell-based benchmarks into practical workflows while showing how to distinguish cytoskeletal autophagy responses from secondary oxidative-stress effects.

• Lyotropic Assembly of Coil–Bottlebrush Diblocks

  2026-09-02

  Rodriguez, Mahanthappa, and Lodge examine how coil-block-bottlebrush diblock copolymers self-assemble in coil-selective alkylimidazolium ionic liquids. Their central finding is that morphology depends only weakly on ionic-liquid alkyl-chain length despite substantial changes in solvent selectivity, offering a useful constraint for designing lyotropic nanostructured materials.

• Pazopanib (GW-786034): Mechanism & Research Guide

  2026-09-02

  Pazopanib, also called GW-786034, is a multi-targeted receptor tyrosine kinase inhibitor that blocks VEGFR, PDGFR, FGFR, c-Kit, and c-Fms signaling. Its reported anti-angiogenic and tumor growth suppression activity supports cancer research in vascularized tumor models, while ATRX-deficient glioma findings provide a biomarker-informed rationale for additional validation.

• Silymarin: From Chemical Identity to Assay Insight

  2026-09-01

  Silymarin is a chemically complex milk thistle extract whose flavonolignan composition directly shapes experimental interpretation. This guide connects stereochemical chemistry with assay design across oxidative stress, cancer, metabolic, and antiviral research.

• Thiazovivin (A5506): Practical ROCK Inhibitor Guide

  2026-09-01

  Thiazovivin (SKU A5506) is a ROCK inhibitor used to address poor cell recovery after trypsinization and to support fibroblast reprogramming workflows for induced pluripotent stem cell generation. This guide covers material handling, controls, and optimization boundaries; it is intended for stem cell research only and not for diagnostic, therapeutic, or medical use.

• In Vitro Drug Responses: Beyond Relative Viability

  2026-08-31

  Hannah Schwartz’s dissertation shows that relative viability and fractional viability capture different dimensions of anticancer drug response: growth inhibition and cell killing. Its central practical contribution is a more discriminating in vitro framework that considers response magnitude, composition, and timing rather than treating a single viability value as a complete pharmacologic phenotype.

• Heart–Brain Axis Dysregulation in PTSD Mice

  2026-08-31

  A 2026 European Journal of Pharmacology study identifies a vagus-mediated pathway linking sympathetically driven cardiac overactivation to insular cortex hyperactivity and PTSD-like behavior in mice. Its use of isoproterenol, vagotomy, electrophysiology, and propranolol provides a mechanistic framework for studying β-adrenergic receptor signaling pathway effects across cardiovascular and neurobehavioral systems.

• Anlotinib Hydrochloride: From Angiogenesis to Translation

  2026-08-30

  Anlotinib hydrochloride offers translational researchers a mechanistically coherent way to connect VEGFR2, PDGFRβ, FGFR1, endothelial phenotypes, ERK signaling, and tumor-response hypotheses in cancer research.

• Ibrutinib (PCI-32765) BTK Inhibitor Workflow

  2026-08-29

  Build cleaner B-cell experiments with Ibrutinib (PCI-32765), from solvent handling and BCR stimulation to washout designs that exploit irreversible BTK inhibition. A reference study in amyloid models provides a useful framework for factorial controls and orthogonal phenotyping, while its non-B-cell context defines important translational limits.

8093 records 1/540 page Next 12345 下5页 Last page